nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ABCB1—adrenal gland cancer	0.466	1	CbGaD
Caffeine—PIK3CD—adrenal medulla—adrenal gland cancer	0.0346	0.154	CbGeAlD
Caffeine—PIK3CB—adrenal medulla—adrenal gland cancer	0.0302	0.135	CbGeAlD
Caffeine—PIK3CA—adrenal medulla—adrenal gland cancer	0.0299	0.133	CbGeAlD
Caffeine—PIK3CD—brown adipose tissue—adrenal gland cancer	0.0199	0.0889	CbGeAlD
Caffeine—PIK3CB—brown adipose tissue—adrenal gland cancer	0.0174	0.0776	CbGeAlD
Caffeine—PIK3CA—brown adipose tissue—adrenal gland cancer	0.0172	0.0768	CbGeAlD
Caffeine—PRKDC—adrenal cortex—adrenal gland cancer	0.00357	0.0159	CbGeAlD
Caffeine—ATM—cardiac atrium—adrenal gland cancer	0.00312	0.0139	CbGeAlD
Caffeine—PRKDC—cardiac atrium—adrenal gland cancer	0.00295	0.0132	CbGeAlD
Caffeine—PIK3CB—adrenal cortex—adrenal gland cancer	0.00292	0.013	CbGeAlD
Caffeine—PIK3CA—adrenal cortex—adrenal gland cancer	0.00289	0.0129	CbGeAlD
Caffeine—PRKDC—pituitary gland—adrenal gland cancer	0.00288	0.0129	CbGeAlD
Caffeine—ATM—adrenal gland—adrenal gland cancer	0.00272	0.0121	CbGeAlD
Caffeine—PIK3CD—pituitary gland—adrenal gland cancer	0.0027	0.0121	CbGeAlD
Caffeine—CYP1A2—urine—adrenal gland cancer	0.00262	0.0117	CbGeAlD
Caffeine—PRKDC—adrenal gland—adrenal gland cancer	0.00257	0.0115	CbGeAlD
Caffeine—CYP2C9—urine—adrenal gland cancer	0.00248	0.0111	CbGeAlD
Caffeine—PIK3CB—gonad—adrenal gland cancer	0.00242	0.0108	CbGeAlD
Caffeine—PIK3CD—adrenal gland—adrenal gland cancer	0.00241	0.0108	CbGeAlD
Caffeine—PIK3CB—cardiac atrium—adrenal gland cancer	0.00241	0.0108	CbGeAlD
Caffeine—PIK3CA—gonad—adrenal gland cancer	0.00239	0.0107	CbGeAlD
Caffeine—PIK3CA—cardiac atrium—adrenal gland cancer	0.00239	0.0107	CbGeAlD
Caffeine—PIK3CB—pituitary gland—adrenal gland cancer	0.00236	0.0105	CbGeAlD
Caffeine—CYP2E1—urine—adrenal gland cancer	0.00235	0.0105	CbGeAlD
Caffeine—PIK3CA—pituitary gland—adrenal gland cancer	0.00233	0.0104	CbGeAlD
Caffeine—PIK3CB—adrenal gland—adrenal gland cancer	0.00211	0.00939	CbGeAlD
Caffeine—RYR1—adrenal gland—adrenal gland cancer	0.00208	0.0093	CbGeAlD
Caffeine—PIK3CA—adrenal gland—adrenal gland cancer	0.00208	0.0093	CbGeAlD
Caffeine—CYP3A4—urine—adrenal gland cancer	0.00189	0.00845	CbGeAlD
Caffeine—CYP2D6—urine—adrenal gland cancer	0.00186	0.00831	CbGeAlD
Caffeine—ADORA2B—pituitary gland—adrenal gland cancer	0.00172	0.00766	CbGeAlD
Caffeine—ADORA2A—gonad—adrenal gland cancer	0.00146	0.00653	CbGeAlD
Caffeine—ADORA2A—adrenal gland—adrenal gland cancer	0.00128	0.00569	CbGeAlD
Caffeine—ADORA1—cardiac atrium—adrenal gland cancer	0.00126	0.00563	CbGeAlD
Caffeine—PDE4B—gonad—adrenal gland cancer	0.000935	0.00417	CbGeAlD
Caffeine—PDE4B—cardiac atrium—adrenal gland cancer	0.000934	0.00416	CbGeAlD
Caffeine—PDE4B—pituitary gland—adrenal gland cancer	0.000912	0.00407	CbGeAlD
Caffeine—PDE4B—adrenal gland—adrenal gland cancer	0.000815	0.00363	CbGeAlD
Caffeine—CYP1B1—gonad—adrenal gland cancer	0.000801	0.00357	CbGeAlD
Caffeine—CYP1B1—pituitary gland—adrenal gland cancer	0.000782	0.00349	CbGeAlD
Caffeine—CYP1B1—adrenal gland—adrenal gland cancer	0.000698	0.00311	CbGeAlD
Caffeine—CYP2C8—pituitary gland—adrenal gland cancer	0.000599	0.00267	CbGeAlD
Caffeine—CYP1A1—cardiac atrium—adrenal gland cancer	0.000566	0.00252	CbGeAlD
Caffeine—CYP2E1—adrenal gland—adrenal gland cancer	0.00045	0.00201	CbGeAlD
Caffeine—ABCB1—adrenal cortex—adrenal gland cancer	0.000355	0.00158	CbGeAlD
Caffeine—ABCB1—gonad—adrenal gland cancer	0.000294	0.00131	CbGeAlD
Caffeine—ABCB1—pituitary gland—adrenal gland cancer	0.000287	0.00128	CbGeAlD
Caffeine—ABCB1—adrenal gland—adrenal gland cancer	0.000256	0.00114	CbGeAlD
Caffeine—PIK3CD—Adaptive Immune System—EGFR—adrenal gland cancer	4.82e-05	0.000156	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—GNAS—adrenal gland cancer	4.77e-05	0.000154	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	4.73e-05	0.000153	CbGpPWpGaD
Caffeine—PIK3CD—Disease—BRAF—adrenal gland cancer	4.72e-05	0.000152	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TP53—adrenal gland cancer	4.69e-05	0.000151	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.6e-05	0.000149	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—POMC—adrenal gland cancer	4.58e-05	0.000148	CbGpPWpGaD
Caffeine—PRKDC—Immune System—EGFR—adrenal gland cancer	4.57e-05	0.000148	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MEN1—adrenal gland cancer	4.55e-05	0.000147	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CDC42—adrenal gland cancer	4.53e-05	0.000146	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—POMC—adrenal gland cancer	4.53e-05	0.000146	CbGpPWpGaD
Caffeine—PIK3CB—Disease—BAD—adrenal gland cancer	4.52e-05	0.000146	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PRKACA—adrenal gland cancer	4.5e-05	0.000145	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CDC42—adrenal gland cancer	4.49e-05	0.000145	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PRKACA—adrenal gland cancer	4.45e-05	0.000144	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—EGFR—adrenal gland cancer	4.38e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IGF2—adrenal gland cancer	4.37e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—CTNNB1—adrenal gland cancer	4.36e-05	0.000141	CbGpPWpGaD
Caffeine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	4.35e-05	0.00014	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—GNAS—adrenal gland cancer	4.33e-05	0.00014	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IGF2—adrenal gland cancer	4.33e-05	0.00014	CbGpPWpGaD
Caffeine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	4.31e-05	0.000139	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—GNAS—adrenal gland cancer	4.29e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—POMC—adrenal gland cancer	4.28e-05	0.000138	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IGF1R—adrenal gland cancer	4.22e-05	0.000136	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PRKACA—adrenal gland cancer	4.21e-05	0.000136	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—EGFR—adrenal gland cancer	4.21e-05	0.000136	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IGF1R—adrenal gland cancer	4.19e-05	0.000135	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TERT—adrenal gland cancer	4.17e-05	0.000135	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—POMC—adrenal gland cancer	4.16e-05	0.000134	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.16e-05	0.000134	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.12e-05	0.000133	CbGpPWpGaD
Caffeine—PIK3CB—Disease—BRAF—adrenal gland cancer	4.11e-05	0.000133	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—POMC—adrenal gland cancer	4.11e-05	0.000133	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TERT—adrenal gland cancer	4.09e-05	0.000132	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TP53—adrenal gland cancer	4.08e-05	0.000132	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—GNAS—adrenal gland cancer	4.08e-05	0.000132	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.06e-05	0.000131	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—MED12—adrenal gland cancer	4.03e-05	0.00013	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—ABCB1—adrenal gland cancer	4.01e-05	0.000129	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—POMC—adrenal gland cancer	4e-05	0.000129	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—POMC—adrenal gland cancer	3.89e-05	0.000126	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.89e-05	0.000125	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—BAD—adrenal gland cancer	3.86e-05	0.000124	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.85e-05	0.000124	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CDC42—adrenal gland cancer	3.82e-05	0.000123	CbGpPWpGaD
Caffeine—PIK3CD—Disease—PTGS2—adrenal gland cancer	3.81e-05	0.000123	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CDC42—adrenal gland cancer	3.77e-05	0.000122	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.73e-05	0.00012	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—CTNNB1—adrenal gland cancer	3.69e-05	0.000119	CbGpPWpGaD
Caffeine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	3.68e-05	0.000119	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IGF2—adrenal gland cancer	3.68e-05	0.000119	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—GNAS—adrenal gland cancer	3.65e-05	0.000118	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IGF2—adrenal gland cancer	3.64e-05	0.000117	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TERT—adrenal gland cancer	3.64e-05	0.000117	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—MED12—adrenal gland cancer	3.63e-05	0.000117	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—BAD—adrenal gland cancer	3.63e-05	0.000117	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—GNAS—adrenal gland cancer	3.61e-05	0.000116	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TERT—adrenal gland cancer	3.6e-05	0.000116	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.6e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CDC42—adrenal gland cancer	3.57e-05	0.000115	CbGpPWpGaD
Caffeine—PIK3CA—Disease—BAD—adrenal gland cancer	3.56e-05	0.000115	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IGF1R—adrenal gland cancer	3.56e-05	0.000115	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.55e-05	0.000115	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—POMC—adrenal gland cancer	3.54e-05	0.000114	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—SDHD—adrenal gland cancer	3.53e-05	0.000114	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—RRM1—adrenal gland cancer	3.53e-05	0.000114	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—RRM1—adrenal gland cancer	3.52e-05	0.000114	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—SDHD—adrenal gland cancer	3.52e-05	0.000114	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IGF1R—adrenal gland cancer	3.52e-05	0.000114	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—POMC—adrenal gland cancer	3.49e-05	0.000113	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.48e-05	0.000112	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—EGFR—adrenal gland cancer	3.45e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IGF2—adrenal gland cancer	3.44e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—GNAS—adrenal gland cancer	3.41e-05	0.00011	CbGpPWpGaD
Caffeine—PIK3CD—Disease—CTNNB1—adrenal gland cancer	3.41e-05	0.00011	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.38e-05	0.000109	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—POMC—adrenal gland cancer	3.35e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IGF1R—adrenal gland cancer	3.33e-05	0.000107	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SDHD—adrenal gland cancer	3.33e-05	0.000107	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—RRM1—adrenal gland cancer	3.33e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PTGS2—adrenal gland cancer	3.32e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—EGFR—adrenal gland cancer	3.31e-05	0.000107	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—BRAF—adrenal gland cancer	3.3e-05	0.000107	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	3.29e-05	0.000106	CbGpPWpGaD
Caffeine—PIK3CA—Disease—BRAF—adrenal gland cancer	3.24e-05	0.000105	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—CTNNB1—adrenal gland cancer	3.22e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—adrenal gland cancer	3.22e-05	0.000104	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—POMC—adrenal gland cancer	3.21e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—EGFR—adrenal gland cancer	3.2e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PTGS2—adrenal gland cancer	3.19e-05	0.000103	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—BAD—adrenal gland cancer	3.16e-05	0.000102	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—BAD—adrenal gland cancer	3.13e-05	0.000101	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.09e-05	9.96e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TERT—adrenal gland cancer	3.06e-05	9.89e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	3.05e-05	9.85e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	3.05e-05	9.85e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.03e-05	9.79e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TERT—adrenal gland cancer	3.03e-05	9.77e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.03e-05	9.77e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—CTNNB1—adrenal gland cancer	2.97e-05	9.59e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDC42—adrenal gland cancer	2.95e-05	9.52e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PRKACA—adrenal gland cancer	2.94e-05	9.48e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—EGFR—adrenal gland cancer	2.93e-05	9.44e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—POMC—adrenal gland cancer	2.92e-05	9.41e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—POMC—adrenal gland cancer	2.89e-05	9.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—BRAF—adrenal gland cancer	2.88e-05	9.3e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.87e-05	9.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TERT—adrenal gland cancer	2.87e-05	9.25e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—BRAF—adrenal gland cancer	2.85e-05	9.21e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF2—adrenal gland cancer	2.84e-05	9.17e-05	CbGpPWpGaD
Caffeine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.84e-05	9.17e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—GNAS—adrenal gland cancer	2.82e-05	9.09e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—EGFR—adrenal gland cancer	2.79e-05	9.01e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—adrenal gland cancer	2.78e-05	8.98e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—EGFR—adrenal gland cancer	2.77e-05	8.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—POMC—adrenal gland cancer	2.75e-05	8.87e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.75e-05	8.87e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—EGFR—adrenal gland cancer	2.7e-05	8.72e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—BAD—adrenal gland cancer	2.67e-05	8.6e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.66e-05	8.58e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.66e-05	8.58e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.65e-05	8.55e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—BAD—adrenal gland cancer	2.63e-05	8.5e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MED12—adrenal gland cancer	2.63e-05	8.49e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.63e-05	8.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—adrenal gland cancer	2.62e-05	8.45e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.59e-05	8.36e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—EGFR—adrenal gland cancer	2.55e-05	8.23e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.54e-05	8.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—CTNNB1—adrenal gland cancer	2.54e-05	8.19e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.5e-05	8.08e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.5e-05	8.08e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.5e-05	8.07e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—BAD—adrenal gland cancer	2.49e-05	8.05e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.48e-05	8.01e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.48e-05	8.01e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MED12—adrenal gland cancer	2.48e-05	8.01e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—POMC—adrenal gland cancer	2.46e-05	7.93e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—POMC—adrenal gland cancer	2.43e-05	7.84e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—BRAF—adrenal gland cancer	2.43e-05	7.83e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.4e-05	7.74e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—BRAF—adrenal gland cancer	2.4e-05	7.74e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CTNNB1—adrenal gland cancer	2.39e-05	7.71e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—GNAS—adrenal gland cancer	2.38e-05	7.69e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TERT—adrenal gland cancer	2.37e-05	7.64e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—EGFR—adrenal gland cancer	2.35e-05	7.6e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—EGFR—adrenal gland cancer	2.35e-05	7.59e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—CTNNB1—adrenal gland cancer	2.34e-05	7.56e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ABCB1—adrenal gland cancer	2.34e-05	7.54e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—EGFR—adrenal gland cancer	2.32e-05	7.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—POMC—adrenal gland cancer	2.3e-05	7.42e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.27e-05	7.34e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—BRAF—adrenal gland cancer	2.27e-05	7.33e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.22e-05	7.16e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—EGFR—adrenal gland cancer	2.2e-05	7.1e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—adrenal gland cancer	2.19e-05	7.08e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GNAS—adrenal gland cancer	2.15e-05	6.93e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	2.12e-05	6.85e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	2.12e-05	6.85e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.11e-05	6.8e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CTNNB1—adrenal gland cancer	2.08e-05	6.72e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.06e-05	6.66e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BAD—adrenal gland cancer	2.06e-05	6.64e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.03e-05	6.56e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.01e-05	6.5e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—EGFR—adrenal gland cancer	2.01e-05	6.49e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MED12—adrenal gland cancer	1.98e-05	6.4e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	1.92e-05	6.2e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.92e-05	6.18e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—POMC—adrenal gland cancer	1.9e-05	6.12e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—adrenal gland cancer	1.89e-05	6.11e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—adrenal gland cancer	1.87e-05	6.05e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.87e-05	6.03e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—adrenal gland cancer	1.86e-05	5.99e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.85e-05	5.97e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.82e-05	5.86e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	1.81e-05	5.84e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.77e-05	5.71e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.75e-05	5.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.73e-05	5.59e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.66e-05	5.36e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.65e-05	5.34e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—adrenal gland cancer	1.65e-05	5.32e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CTNNB1—adrenal gland cancer	1.64e-05	5.29e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.64e-05	5.28e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.64e-05	5.28e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—adrenal gland cancer	1.63e-05	5.27e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.62e-05	5.23e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—POMC—adrenal gland cancer	1.6e-05	5.18e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—adrenal gland cancer	1.59e-05	5.13e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.58e-05	5.11e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	1.56e-05	5.02e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.55e-05	5.01e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	1.53e-05	4.93e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.52e-05	4.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GNAS—adrenal gland cancer	1.47e-05	4.73e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.45e-05	4.67e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.45e-05	4.67e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	1.44e-05	4.65e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.41e-05	4.56e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—adrenal gland cancer	1.39e-05	4.48e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—adrenal gland cancer	1.38e-05	4.47e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—adrenal gland cancer	1.37e-05	4.43e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—adrenal gland cancer	1.37e-05	4.43e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.36e-05	4.4e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.35e-05	4.37e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.35e-05	4.36e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.34e-05	4.34e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.32e-05	4.26e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.32e-05	4.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—adrenal gland cancer	1.3e-05	4.19e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—adrenal gland cancer	1.28e-05	4.13e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.22e-05	3.94e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.17e-05	3.78e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—adrenal gland cancer	1.17e-05	3.77e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.15e-05	3.72e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.15e-05	3.72e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—adrenal gland cancer	1.15e-05	3.72e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.13e-05	3.64e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.1e-05	3.56e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.09e-05	3.53e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—adrenal gland cancer	1.09e-05	3.52e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.08e-05	3.5e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.07e-05	3.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—adrenal gland cancer	1.07e-05	3.46e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—POMC—adrenal gland cancer	1.05e-05	3.38e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.05e-05	3.37e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—POMC—adrenal gland cancer	9.88e-06	3.19e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	9.35e-06	3.02e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	9.18e-06	2.96e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—POMC—adrenal gland cancer	9.05e-06	2.92e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—adrenal gland cancer	9.01e-06	2.91e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.91e-06	2.87e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	8.36e-06	2.7e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.34e-06	2.69e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—POMC—adrenal gland cancer	7.89e-06	2.55e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	7.88e-06	2.54e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.43e-06	2.4e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—POMC—adrenal gland cancer	7.37e-06	2.38e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	7.22e-06	2.33e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.22e-06	2.33e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7.08e-06	2.29e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—POMC—adrenal gland cancer	6.3e-06	2.03e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	6.29e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	5.93e-06	1.91e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	5.88e-06	1.9e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	5.02e-06	1.62e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.86e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.88e-06	1.25e-05	CbGpPWpGaD
